Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001140361-24-046918
Filing Date
2024-11-14
Accepted
2024-11-14 16:17:40
Documents
3
Group Members
INNOVIVA STRATEGIC OPPORTUNITIES LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A ef20038691_sc13da.htm SC 13D/A 81154
2 EXHIBIT 99.1 ef20038691_ex99-1.htm EX-99.1 31065
3 EXHIBIT 99.2 ef20038691_ex99-2.htm EX-99.2 30835
  Complete submission text file 0001140361-24-046918.txt   145179
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Subject) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-44887 | Film No.: 241462659
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filed by) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)